After waking up from the procedure, he told me he could take full breaths for the first time in years,” Dr. Mark Sigler said ...

The growing prevalence of COPD among women can be attributed to a combination of biological, environmental, and societal ...

AstraZeneca’s respiratory and immunology portfolio is driving significant growth, with R&I assets forecasted to account for ...

For many in the Texas Panhandle, a groundbreaking procedure is offering a new lease on life ... is a minimally invasive treatment for severe or very severe COPD and emphysema.

If these trials confirm the findings, benralizumab could become the first new therapy approved for eosinophilic exacerbations ...

Study reveals the Prospector calculator reduces antibiotic prescriptions in COPD exacerbations, improving outcomes and ...

Multiple chemicals in cigarette smoke and e-cigarettes alter the function of a key type of lung immune cell. Cigarette ...

The programme – spearheaded by The Academic Respiratory Initiative for Pulmonary Health (Tariph) Centre under LKCMedicine – ...

A Midtown-based medical device startup is carving a niche in the growing field of treatments to address chronic lung disease.

Early treatment will prevent the condition from ... worsening symptoms, or new symptoms. COPD is a serious and chronic lung condition. Two conditions can cause it: emphysema and chronic bronchitis.

People with COPD experience more falls and related injuries requiring medical care when using common fall-risk increasing ...